The new report titled ‘Global Cancer Imaging Systems Market,’ published by Emergen Research, is a vivid presentation of the global Cancer Imaging Systems market, with utmost focus on the forecast market size, share, value, and volume over the projected timeline. The cancer imaging systems market is observing high demand attributed to the increasing incidence of cancer. Cancer significantly impacts the societal and economic growth in the US and worldwide and is a major contributor to the cost burden of disease. It has been anticipated that 1,806,590 new cancer cases are likely to be diagnosed in the US in 2020, and 606,520 deaths will occur owing to the disease.
The report throws light on the current economic landscape of this business vertical and evaluates the top market trends. It has been compiled through significant primary research, including surveys, interviews, and expert analysts’ observations. The Global Cancer Imaging Systems Market report provides full coverage of the companies’ data, including details about their production and manufacturing capacity, product portfolio, business overview, revenue, gross profit margins, sales network and distribution channel, financial standing, and market position. Growing technological advancements and increased investments in cancer imaging are causative of the rapid growth of the market. Hologic, Inc., in November 2019, received approval from the US Food and Drug Administration (FDA) for its 3DQuorum™ Imaging Technology, driven by Genius AI™. The technology works simultaneously with Hologic’s Clarity HD™ high-resolution imaging technology and helps radiologists reduce tomosynthesis image volume by 66.0%. The breast imaging system owing to such advancements would produce higher-resolution 3D images, better workflow, and an improved mammography experience for patents necessitating low radiation dose.
To get a sample copy of the Global Cancer Imaging Systems Market report, visit @ https://www.emergenresearch.com/request-sample/222:
The Global Cancer Imaging Systems Market report presents comprehensive information covering insightful data for businesses and investors for the time period of 2020-2027. The report studies the historical data of the Cancer Imaging Systems market and offers valuable information about the key segments and sub-segments, revenue generation, demand and supply scenario, trends, and other vital aspects. The report also studies business strategies and strategic alliances undertaken by companies to gain a robust footing in the market. The report sheds light on the mergers and acquisitions, collaborations, joint ventures, brand promotions and product launches, agreements and partnerships, and corporate and government deals. The comprehensive analysis of the competitive landscape offers the readers a deeper understanding about the competitors.
Top competitors of the Cancer Imaging Systems Market profiled in the report include:
- GE Healthcare, Hitachi Medical, Becton, Dickinson, and Company, Thermo Fisher Scientific Inc., CR Bard Inc., Agilent Technologies, Abbott, Illumina Inc., Roche, and Philips Healthcare, among others.
Key Highlights From The Report
- In July 2019, Agilent Technologies Inc. made an announcement about the signing of an agreement to buy BioTek Instruments, a private firm, for USD 1.17 billion. BioTek is involved in designing, producing, and distributing groundbreaking life science instrumentation, including cell imaging systems.
- MRI offers the benefit of imaging soft body tissue parts that are occasionally hard to view using other types of modalities. MRI is excellent at identifying and locating some cancers. Moreover, an MRI deploying contrast dye is the most appropriate brain and spinal cord tumor imaging technique.
To learn more details about the Global Cancer Imaging Systems Market report, visit @ https://www.emergenresearch.com/industry-report/cancer-imaging-systems-market:
The report aims to deliver a comprehensive understanding of the Cancer Imaging Systems market growth and expansion in each key region of the world. It offers accurate estimations about the expected market size and growth over the projected timeline of 2020-2027.
Emergen Research has segmented the global cancer imaging systems market on the basis of imaging systems, application, end-users, and region:
- Imaging Systems Outlook (Revenue, USD Billion; 2017-2027)
- Computed Tomography (CT)
- Magnetic Resonance Imaging (MRI)
- Positron Emission Tomography (PET)
- Application Outlook (Revenue, USD Billion; 2017-2027)
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- End-Users Outlook (Revenue, USD Billion; 2017-2027)
- Hospitals & Clinics
- Diagnostic Centers
The report offers a comprehensive analysis of the current growth opportunities for various regions of the Cancer Imaging Systems market. It gauges the revenue shares of these regions over the forecast timeline. Furthermore, the report analyzes the year-on-year growth rate of these regions over the forecast duration. The leading geographic regions encompassed in the report include North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
The research report on the Cancer Imaging Systems market is formulated through extensive primary and secondary research along with qualitative and quantitative analysis of vital aspects of the market. The insightful data is further validated and verified by the industry professionals. The report strives to offer deeper insights into the overall market scenario of the Cancer Imaging Systems business sphere.
Proceed To Buy: https://www.emergenresearch.com/select-license/222
Table of Content
Chapter 1. Methodology & Sources
1.1. Alopecia Market Definition
1.2. Research Scope
1.4. Research Sources
1.4.3. Paid Sources
1.5. Alopecia Market Estimation Technique
Chapter 2. Executive Summary
2.1. Summary Snapshot, 2021-2028
Chapter 3. Key Insights
Chapter 4. Alopecia Market Segmentation & Impact Analysis
4.1. Alopecia Market Material Segmentation Analysis
4.2. Industrial Outlook
4.2.1. Alopecia Market indicators analysis
4.2.2. Alopecia Market drivers analysis
22.214.171.124. Rapid urbanization and industrialization
126.96.36.199. Stringent government regulations regarding carbon emissions
188.8.131.52. Increasing prevalence of respiratory diseases
184.108.40.206. Rising need to enhance indoor air quality
4.2.3. Alopecia Market restraints analysis
220.127.116.11. High cost associated with the maintenance of Alopecia products
18.104.22.168. Availability of renewable sources of energy
4.3. Technological Insights
4.4. Regulatory Framework
4.5. Porter’s Five Forces Analysis
4.6. Competitive Metric Space Analysis
4.7. Price trend Analysis
4.8. Covid-19 Impact Analysis
Key Benefits of Buying the Global Cancer Imaging Systems Report:
- Comprehensive analysis of the changing competitive landscape
- Assists in decision making processes for the businesses along with detailed strategic planning methodologies
- The report offers an 8-year forecast and assessment of the Global Cancer Imaging Systems Market
- Helps in understanding the key product segments and their estimated growth rate
- In-depth analysis of market drivers, restraints, trends, and opportunities
- Comprehensive regional analysis of the Global Cancer Imaging Systems Market
The report considers the following timeline for market estimation:
- Historical Years: 2017-2018
- Base Year: 2019
- Estimated Year: 2020
- Forecast Years: 2020-2027
Request customization of the report: https://www.emergenresearch.com/request-for-customization/222
Thank you for reading our report. If you have any requests for customization of the latest report, kindly get in touch with us. Our team will assist you and ensure the report is designed as per your requirements.
Read similar reports by Emergen Research:
In-Vitro Fertilization Market: https://www.emergenresearch.com/industry-report/in-vitro-fertilization-market
Newborn Screening Market: https://www.emergenresearch.com/industry-report/new-born-screening-market
RFID in Healthcare Market: https://www.emergenresearch.com/industry-report/rfid-in-healthcare-market
Next-Generation Sequencing Market: https://www.emergenresearch.com/industry-report/next-generation-sequencing-market
Regenerative Medicine Market: https://www.emergenresearch.com/industry-report/regenerative-medicine-market
At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.
Contact Us: Eric Lee Corporate Sales Specialist Emergen Research | Web: www.emergenresearch.com Direct Line: +1 (604) 757-9756 E-mail: firstname.lastname@example.org Facebook | LinkedIn | Twitter | Blogs